CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Innovation often pays off, and this biotech could cement its innovative capabilities in the next few years.

CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual ...

When CRISPR cuts a gene flanked by short, repeating DNA sequences, the cell’s repair machinery gets confused. It simply zips ...

CRISPR recently raised nearly $600 million through a private offering, which weighed down its share price. The company has an ...

Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...

Banas is associate director of research at the Gene Editing Institute at ChristianaCare, where Kmiec is founder and executive director. The medical promise of CRISPR gene editing can be seen most ...

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based ...

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...